SG11201601767YA - Method of producing pyrazino[2,1-c][1,2,4]triazine compound - Google Patents

Method of producing pyrazino[2,1-c][1,2,4]triazine compound

Info

Publication number
SG11201601767YA
SG11201601767YA SG11201601767YA SG11201601767YA SG11201601767YA SG 11201601767Y A SG11201601767Y A SG 11201601767YA SG 11201601767Y A SG11201601767Y A SG 11201601767YA SG 11201601767Y A SG11201601767Y A SG 11201601767YA SG 11201601767Y A SG11201601767Y A SG 11201601767YA
Authority
SG
Singapore
Prior art keywords
pyrazino
producing
triazine compound
triazine
compound
Prior art date
Application number
SG11201601767YA
Inventor
Minetaka Isomura
Yuki Kosaka
Mitsuo Nagai
Takenao Odagami
Hiroyuki Kouji
Original Assignee
Prism Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prism Pharma Co Ltd filed Critical Prism Pharma Co Ltd
Publication of SG11201601767YA publication Critical patent/SG11201601767YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201601767YA 2013-09-11 2014-09-09 Method of producing pyrazino[2,1-c][1,2,4]triazine compound SG11201601767YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013188361 2013-09-11
PCT/JP2014/073821 WO2015037587A1 (en) 2013-09-11 2014-09-09 Method of producing pyrazino[2,1-c][1,2,4]triazine compound

Publications (1)

Publication Number Publication Date
SG11201601767YA true SG11201601767YA (en) 2016-04-28

Family

ID=52665689

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201601767YA SG11201601767YA (en) 2013-09-11 2014-09-09 Method of producing pyrazino[2,1-c][1,2,4]triazine compound

Country Status (11)

Country Link
US (1) US20160215007A1 (en)
EP (1) EP3045464A1 (en)
JP (1) JPWO2015037587A1 (en)
KR (1) KR20160075505A (en)
CN (1) CN105829331A (en)
AU (1) AU2014319460A1 (en)
CA (1) CA2923530A1 (en)
MX (1) MX2016003185A (en)
RU (1) RU2016113375A (en)
SG (1) SG11201601767YA (en)
WO (1) WO2015037587A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8302353A (en) * 1983-07-01 1985-02-01 Stichting Katholieke Univ PHOSPHORIZATION AGENT; METHOD FOR PREPARING THEREOF METHOD FOR PHOSPHORYLATING AN ORGANIC HYDROXYL OR AMINE COMPOUND
US7671054B1 (en) * 2001-10-12 2010-03-02 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
MX2010013277A (en) * 2008-06-06 2011-04-27 Prism Biolab Corp Alpha helix mimetics and methods relating thereto.
CA2758904C (en) * 2009-04-15 2017-04-04 Jw Pharmaceutical Corporation Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
CN103930113B (en) * 2011-08-09 2016-08-17 Jw制药公司 For preventing and treat the compositions comprising pyrazine pyrrolotriazine derivatives of nonsmall-cell lung cancer

Also Published As

Publication number Publication date
KR20160075505A (en) 2016-06-29
CN105829331A (en) 2016-08-03
WO2015037587A1 (en) 2015-03-19
JPWO2015037587A1 (en) 2017-03-02
CA2923530A1 (en) 2015-03-19
US20160215007A1 (en) 2016-07-28
AU2014319460A1 (en) 2016-04-14
MX2016003185A (en) 2016-12-09
EP3045464A1 (en) 2016-07-20
RU2016113375A (en) 2017-10-12

Similar Documents

Publication Publication Date Title
EP2955169A4 (en) Novel aryl compound and method for producing same
EP3042960A4 (en) Method for producing ambrein
EP3064488A4 (en) Polythiol compound and method for producing same
EP3037407A4 (en) Method for producing 1,5-pentadiamine
PT2978793T (en) Flame-resistant polyamide, method for the production of said flame-resistant polyamide, and use of said flame-resistant polyamide
EP3061352A4 (en) Method for producing kakiage
SG11201508263WA (en) Method for producing cyclohexanone compound
IL243737A0 (en) Novel triazine derivative
EP3018159A4 (en) Method of producing oxymethylene copolymer
SG11201507951SA (en) Method for producing 2,7-octadien-1-ol
EP3020741A4 (en) Method for producing polydioxolane
PL2964607T3 (en) Process for the preparation of halogen-n, n-dimethylbenzylamines
EP3061851A4 (en) Method for producing plated article
EP3088382A4 (en) Method for producing nitro compound
PL3004065T3 (en) Method for producing pyridazine compound
HUE037141T2 (en) Method for producing 1,1-dibromo-1-fluoroethane
PL2956246T3 (en) Method for producing compound elements
EP3006476A4 (en) Method for producing oxymethylene copolymer
EP3053908A4 (en) METHOD FOR PRODUCING alpha-HALOGENOACETOPHENON COMPOUND, AND alpha-BROMOACETOPHENON COMPOUND
EP3026047A4 (en) Method for producing heterocyclic compound
EP2987780A4 (en) Polyol-ether compound and method for producing same
PL2980079T3 (en) Method of manufacturing pyridazinone compound
PT2835388T (en) Method for the preparation of aminoplast solutions
EP3023445A4 (en) Method for producing oxymethylene copolymer
EP2891645A4 (en) Production method for compound